SCOPUS 정보 검색 플랫폼

Cornea

Volumn 20, Issue 3, 2001, Pages 306-308

Lomefloxacin is an effective treatment of experimental bacterial keratitis

(4) Kowalski, Regis P a,b Romanowski, Eric G a Yates, Kathleen A a Gordon, Y Jerold a

a UNIVERSITY OF PITTSBURGH MEDICAL CENTER (United States)

b University of Pittsburgh School of Medicine (United States)

Author keywords

Animal models; Ciprofloxacin; Keratitis; Lomefloxacin

Indexed keywords

CIPROFLOXACIN; LOMEFLOXACIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG EFFICACY; KERATITIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RABBIT; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIA; CIPROFLOXACIN; COLONY COUNT, MICROBIAL; CORNEAL STROMA; DRUG EVALUATION, PRECLINICAL; EYE INFECTIONS, BACTERIAL; FLUOROQUINOLONES; KERATITIS; MICROBIAL SENSITIVITY TESTS; MODELS, ANIMAL; OPHTHALMIC SOLUTIONS; QUINOLONES; RABBITS;

EID: 0035086265 PISSN: 02773740 EISSN: None Source Type: Journal
DOI: 10.1097/00003226-200104000-00013 Document Type: Article

Times cited : (14)

References (12)

1
- 0025990159
- Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis
- (1991) Am J Ophthalmol , vol.112 , Issue.SUPPL. 4
- Leibowitz, H.M.¹

2
- 0029121361
- Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group
- (1995) Arch Ophthalmol , vol.113 , pp. 1257-1265
- O'Brien, T.P.¹ Maquire, M.G.² Fink, N.E.³

3
- 0005623989
- Clinical study with 0.3% eye drops (DR 1303) in comparison with ofloxacin 0.3% eye drops (Taravid) in the treatment of acute bacterial conjunctivitis
- May 23-28; Brussels, Belgium
- (1992) Proceedings of the IX Congress of the European Society of Ophthalmology (SOE 92)
- Huguet, P.¹

4
- 0005598184
- Double masked double dummy clinical multicenter trial in Switzerland between lomefloxacin 0.3% (DR 1303) eyedrops and gentamicin 0.3% eye drops in patients with acute bacterial conjunctivitis
- Sept 15-17; Aarau, Switzerland
- (1994) Proceedings of the Annual Congress of the Ophthalmic Society of Switzerland (SOG)
- Guex-Crosier, Y.¹ Nussbaum, R.² Herbert, C.³

5
- 13644259229
- Comparative penetration of lomefloxacin and other quinolones into human phagocytes
- (1992) Am J Medicine , vol.92 , Issue.SUPPL. 4
- Peres, E.J.¹ Garcia, I.² Hernandes, A.P.³

6
- 0005560754
- Penetration of lomefloxacin ophthahnic solution (NY- 198) into the human aqueous humor
- (1991) Jpn Rev Ophthahnol , vol.85 , pp. 493-495
- Kedame, T.¹

7
- 0005578503
- Approved standard. Villanova, PA: National Committee for Clinical Laboratory Standards National Committee for Clinical Laboratory Standards. Document M7-A4
- (1997) Methods for Dilution Antimicrobials Susceptibility Tests for Bacteria that Grow Aerobically, Vol. 7, No. 2, ed. 4 , vol.2

8
- 0009415773
- Bacterial infections of the conjunctiva and cornea
- Albert DM, Jakobiec FA, eds. Philadelphia: WB Saunders
- (1999) Principles and practice of ophthalmology, 2nd ed. , pp. 894-905
- Foulks, G.N.¹ Gordon, J.S.² Kowalski, R.P.³

9
- 0000320148
- Susceptibility to antibiotics: Species incidence and trends
- Lorian V, ed. Baltimore: Williams & Wilkins
- (1996) Antibiotics in laboratory medicine, 4th ed. , pp. 961-975
- Wiedemann, B.¹ Grimm, H.²

10
- 0028216382
- Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis
- (1994) Invest Opthalmol Vis Sci , vol.35 , pp. 1033-1037
- Callegan, M.C.¹ Engel, L.S.² Hill, J.M.³

11
- 0003452701
- Villanova, PA: National Committee for Clinical Laboratory Standards. Document M100-S8
- (1998) Performance Standards for Antimicrobial Susceptibility Testing, Vol. 18, No. 1, eight informational supplement

12
- 0031972087
- Comparison of ciprofloxacin and ofloxacin using human corneal susceptibility levels
- (1998) Cornea , vol.17 , pp. 282-287
- Kowalski, R.P.¹ Karenchak, L.M.² Gordon, Y.J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.